Access

You are not currently logged in.

Access your personal account or get JSTOR access through your library or other institution:

login

Log in to your personal account or through your institution.

If You Use a Screen Reader

This content is available through Read Online (Free) program, which relies on page scans. Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.

Attenuation of Neuroinflammation and Alzheimer's Disease Pathology by Liver x Receptors

Noam Zelcer, Negar Khanlou, Ryan Clare, Qingguang Jiang, Erin G. Reed-Geaghan, Gary E. Landreth, Harry V. Vinters and Peter Tontonoz
Proceedings of the National Academy of Sciences of the United States of America
Vol. 104, No. 25 (Jun. 19, 2007), pp. 10601-10606
Stable URL: http://www.jstor.org/stable/25435979
Page Count: 6
  • Read Online (Free)
  • Subscribe ($19.50)
  • Cite this Item
Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.
Attenuation of Neuroinflammation and Alzheimer's Disease Pathology by Liver x Receptors
Preview not available

Abstract

Alzheimer's disease (AD) is an age-dependent neurodegenerative disease that causes progressive cognitive impairment. The initiation and progression of AD has been linked to cholesterol metabolism and inflammation, processes that can be modulated by liver x receptors (LXRs). We show here that endogenous LXR signaling impacts the development of AD-related pathology. Genetic loss of either Lxrα or Lxrβ in APP/PS1 transgenic mice results in increased amyloid plaque load. LXRs regulate basal and inducible expression of key cholesterol homeostatic genes in the brain and act as potent inhibitors of inflammatory gene expression. Ligand activation of LXRs attenuates the inflammatory response of primary mixed glial cultures to fibrillar amyloid β peptide (fAβ) in a receptor-dependent manner. Furthermore, LXRs promote the capacity of microglia to maintain fAβ-stimulated phagocytosis in the setting of inflammation. These results identify endogenous LXR signaling as an important determinant of AD pathogenesis in mice. We propose that LXRs may be tractable targets for the treatment of AD due to their ability to modulate both lipid metabolic and inflammatory gene expression in the brain.

Page Thumbnails

  • Thumbnail: Page 
10601
    10601
  • Thumbnail: Page 
10602
    10602
  • Thumbnail: Page 
10603
    10603
  • Thumbnail: Page 
10604
    10604
  • Thumbnail: Page 
10605
    10605
  • Thumbnail: Page 
10606
    10606